These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22919658)

  • 1. Serum susceptibility in clinical isolates of Burkholderia cepacia complex bacteria: development of a growth-based assay for high throughput determination.
    Zlosnik JE; Gunaratnam LC; Speert DP
    Front Cell Infect Microbiol; 2012; 2():67. PubMed ID: 22919658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloaking antibodies are prevalent in
    Pham A; Tan KKY; Ledger EL; Smith DJ; Reid DW; Burr L; Chambers DC; Wells TJ
    Front Cell Infect Microbiol; 2024; 14():1426773. PubMed ID: 39193503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015.
    Cipolla L; Rocca F; Martinez C; Aguerre L; Barrios R; Prieto M
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):431-434. PubMed ID: 29055510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of CHROMagar™ B. cepacia agar for the detection of Burkholderia cepacia complex species from sputum samples of patients with cystic fibrosis.
    Maruri-Aransolo A; de Dios Caballero J; Michelena M; Medina-Pascual MJ; Carrasco G; Asensio O; Cols M; Cantón R;
    Eur J Clin Microbiol Infect Dis; 2024 Jul; 43(7):1349-1353. PubMed ID: 38780755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkholderia cepacia complex infections: More complex than the bacterium name suggest.
    Sfeir MM
    J Infect; 2018 Sep; 77(3):166-170. PubMed ID: 30012345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcomes of non-cystic fibrosis patients with Burkholderia cepacia complex bacteremia at a medical center in Taiwan.
    Chang TH; Chuang YC; Wang JT; Sheng WH
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1301-1309. PubMed ID: 34674957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to measure the fitness of Burkholderia cepacia complex isolates.
    Pope CF; Gillespie SH; Moore JE; McHugh TD
    J Med Microbiol; 2010 Jun; 59(Pt 6):679-686. PubMed ID: 20185551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis.
    St Denis M; Ramotar K; Vandemheen K; Tullis E; Ferris W; Chan F; Lee C; Slinger R; Aaron SD
    Chest; 2007 Apr; 131(4):1188-96. PubMed ID: 17426227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Burkholderia contaminans at a cystic fibrosis centre with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance.
    Coutinho CP; Barreto C; Pereira L; Lito L; Melo Cristino J; Sá-Correia I
    J Med Microbiol; 2015 Aug; 64(8):927-935. PubMed ID: 26002942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
    Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
    Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid identification of Burkholderia cepacia complex species recovered from cystic fibrosis patients using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
    Lambiase A; Del Pezzo M; Cerbone D; Raia V; Rossano F; Catania MR
    J Microbiol Methods; 2013 Feb; 92(2):145-9. PubMed ID: 23201483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
    Kenna DTD; Lilley D; Coward A; Martin K; Perry C; Pike R; Hill R; Turton JF
    J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 17-Year Nationwide Study of Burkholderia cepacia Complex Bloodstream Infections Among Patients in the United States Veterans Health Administration.
    El Chakhtoura NG; Saade E; Wilson BM; Perez F; Papp-Wallace KM; Bonomo RA
    Clin Infect Dis; 2017 Oct; 65(8):1253-1259. PubMed ID: 29017247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant
    Zeiser ET; Becka SA; Wilson BM; Barnes MD; LiPuma JJ; Papp-Wallace KM
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate identification of members of the Burkholderia cepacia complex in cystic fibrosis sputum.
    Martinucci M; Roscetto E; Iula VD; Votsi A; Catania MR; De Gregorio E
    Lett Appl Microbiol; 2016 Mar; 62(3):221-9. PubMed ID: 26671758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous coinfection by multiple strains during Burkholderia cepacia complex infection in cystic fibrosis.
    Yang JH; Spilker T; LiPuma JJ
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):95-8. PubMed ID: 16406186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment center.
    Leitão JH; Sousa SA; Cunha MV; Salgado MJ; Melo-Cristino J; Barreto MC; Sá-Correia I
    Eur J Clin Microbiol Infect Dis; 2008 Nov; 27(11):1101-11. PubMed ID: 18600352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first reported case of Burkholderia contaminans in patients with cystic fibrosis in Ireland: from the Sargasso Sea to Irish Children.
    Power RF; Linnane B; Martin R; Power N; Harnett P; Casserly B; O'Connell NH; Dunne CP
    BMC Pulm Med; 2016 Apr; 16(1):57. PubMed ID: 27103163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical course of Burkholderia cepacia complex bacteria respiratory infection in cystic fibrosis patients.
    Correia S; Nascimento C; Pereira L; Cunha MV; Sá-Correia I; Barreto C
    Rev Port Pneumol; 2008; 14(1):5-26. PubMed ID: 18265915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.